These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32679168)

  • 1. B1CTcu5: A frog-derived brevinin-1 peptide with anti-tuberculosis activity.
    Abraham P; Jose L; Maliekal TT; Kumar RA; Kumar KS
    Peptides; 2020 Oct; 132():170373. PubMed ID: 32679168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides.
    Abraham P; Sundaram A; R A; V R; George S; Kumar KS
    PLoS One; 2015; 10(5):e0124210. PubMed ID: 25997127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent cationic antimicrobial peptides against Mycobacterium tuberculosis in vitro.
    Silva S; Santos-Silva A; da Costa JMC; Vale N
    J Glob Antimicrob Resist; 2019 Dec; 19():132-135. PubMed ID: 31154008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity.
    Yathursan S; Wiles S; Read H; Sarojini V
    J Pept Sci; 2019 Nov; 25(11):e3213. PubMed ID: 31515916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.
    Ramón-García S; Mikut R; Ng C; Ruden S; Volkmer R; Reischl M; Hilpert K; Thompson CJ
    Antimicrob Agents Chemother; 2013 May; 57(5):2295-303. PubMed ID: 23478953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between antimicrobial peptides and mycobacteria.
    Gutsmann T
    Biochim Biophys Acta; 2016 May; 1858(5):1034-43. PubMed ID: 26851776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis.
    Aguilar-Pérez C; Gracia B; Rodrigues L; Vitoria A; Cebrián R; Deboosère N; Song OR; Brodin P; Maqueda M; Aínsa JA
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pse-T2, an Antimicrobial Peptide with High-Level, Broad-Spectrum Antimicrobial Potency and Skin Biocompatibility against Multidrug-Resistant Pseudomonas aeruginosa Infection.
    Kang HK; Seo CH; Luchian T; Park Y
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30323036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antibacterial peptides from the skin secretion of the Indian bicoloured frog Clinotarsus curtipes.
    Abraham P; George S; Kumar KS
    Biochimie; 2014 Feb; 97():144-51. PubMed ID: 24161537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tachyplesin and CyLoP-1 as efficient anti-mycobacterial peptides: A novel finding.
    Priya A; Aditya A; Budagavi DP; Chugh A
    Biochim Biophys Acta Biomembr; 2022 Jul; 1864(7):183895. PubMed ID: 35271828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thaulin-1: The first antimicrobial peptide isolated from the skin of a Patagonian frog Pleurodema thaul (Anura: Leptodactylidae: Leiuperinae) with activity against Escherichia coli.
    Marani MM; Perez LO; de Araujo AR; Plácido A; Sousa CF; Quelemes PV; Oliveira M; Gomes-Alves AG; Pueta M; Gameiro P; Tomás AM; Delerue-Matos C; Eaton P; Camperi SA; Basso NG; de Souza de Almeida Leite JR
    Gene; 2017 Mar; 605():70-80. PubMed ID: 28025119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis.
    Linde CM; Hoffner SE; Refai E; Andersson M
    J Antimicrob Chemother; 2001 May; 47(5):575-80. PubMed ID: 11328767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.
    Wang H; Yu Z; Hu Y; Li F; Liu L; Zheng H; Meng H; Yang S; Yang X; Liu J
    Peptides; 2012 Jun; 35(2):285-90. PubMed ID: 22450466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis.
    Rivas-Santiago B; Rivas Santiago CE; Castañeda-Delgado JE; León-Contreras JC; Hancock RE; Hernandez-Pando R
    Int J Antimicrob Agents; 2013 Feb; 41(2):143-8. PubMed ID: 23141114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa.
    Mechkarska M; Attoub S; Sulaiman S; Pantic J; Lukic ML; Conlon JM
    Regul Pept; 2014 Nov; 194-195():69-76. PubMed ID: 25447194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoteric advancement in TB drugs and an overview on the anti-tubercular role of peptides through computational approaches.
    Khusro A; Aarti C; Barbabosa-Pliego A; Salem AZM
    Microb Pathog; 2018 Jan; 114():80-89. PubMed ID: 29174699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy.
    Rao KU; Henderson DI; Krishnan N; Puthia M; Glegola-Madejska I; Brive L; Bjarnemark F; Millqvist Fureby A; Hjort K; Andersson DI; Tenland E; Sturegård E; Robertson BD; Godaly G
    Sci Rep; 2021 Feb; 11(1):4201. PubMed ID: 33603037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of human beta defensin-1 and its motif against active and dormant Mycobacterium tuberculosis.
    Sharma R; Saikia UN; Sharma S; Verma I
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7239-7248. PubMed ID: 28856417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
    Zerbini E; Andreu D; Tonarelli G; Sequeira MD
    Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.